Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The world is stiffing the US on healthcare
The Hill
Sunday, October 12, 2014 - 10:12am
tags:
Texas takes exception to AstraZeneca's marketing of antipsychotic
Seeking Alpha
Saturday, October 11, 2014 - 8:50am
tags:
AstraZeneca, Seroquel, legal
Exact Sciences soars on colon cancer test ruling
Yahoo/AP
Saturday, October 11, 2014 - 8:21am
tags:
EXACT Sciences, colon cancer, Cologuard, diagnostics
Gilead’s new drug is even pricier than Sovaldi
MarketWatch
Saturday, October 11, 2014 - 8:18am
tags:
Gilead, Harvoni, hepatitis C
Gilead Wins U.S. Approval for Hepatitis C Combo Pill
Bloomberg
Friday, October 10, 2014 - 5:51pm
tags:
Gilead Sciences, FDA, Harvoni, hepatitis C
Some Docs Down Under Campaign to Ban Pharma Sales Reps
WSJ Pharmalot
Friday, October 10, 2014 - 5:50pm
tags:
physicians, physician access, Australia, drug reps
Novartis taps Oxford BioMedica in $90M immuno-oncology deal
Fierce Biotech
Friday, October 10, 2014 - 11:50am
tags:
Novarti, Oxford BioMedica, immuno-oncology, lentivirus
FDA clears Akynzeo for chemo-induced nausea and vomiting
Seeking Alpha
Friday, October 10, 2014 - 11:47am
tags:
Akynzeo, Eisai, chemotherapy-induced nausea and vomiting, FDA
Amgen spin-out on deck for IPO
Seeking Alpha
Friday, October 10, 2014 - 11:42am
tags:
Amgen, spinoffs, IPOs, Atara
Prosensa heads to the FDA with its once-failed DMD treatment
Fierce Biotech
Friday, October 10, 2014 - 11:41am
tags:
Prosensa, FDA, Duchenne Muscular Dystrophy, drisapersen
Kimberly-Clark to spin out Halyard Health Oct. 31
Mass Device
Friday, October 10, 2014 - 10:52am
tags:
Kimberly-Clark, Halyard Health, spinoffs, devices
Biomet's Q1 profits plunge despite sales increases
Mass Device
Friday, October 10, 2014 - 10:51am
tags:
earnings, Biomet, devices
GSK Starts First Human Trials For Ebola Vaccine In Africa
Bidness Etc.
Friday, October 10, 2014 - 10:49am
tags:
GSK, clinical trials, ebola virus, Africa, vaccines
Bill and Melinda Gates Foundation funds Pfenex vaccine R&D
Bio-Pharma Reporter
Friday, October 10, 2014 - 10:47am
tags:
Bill Gates, R&D, vaccines, Pfenex
Amgen, Inc. Gives AbbVie Inc the Highest Form of Flattery
Motley Fool
Friday, October 10, 2014 - 10:28am
tags:
Amgen, AbbVie, Humira, biosimilars
Millennium drug Velcade approved for wider use in the US
Boston Globe, MA
Friday, October 10, 2014 - 9:53am
tags:
Velcade, Millennium Pharmaceuticals, non-Hodgkin's lymphoma, Takeda, Janssen
As Hepatitis Pill Harvoni Joins Sovaldi, States Erect Medicaid Hurdles
Forbes
Friday, October 10, 2014 - 9:10am
tags:
Harvoni, Sovaldi, Medicaid, hepatitis C, Gilead Sciences
Aastrom Bio to change name and location
Seeking Alpha
Friday, October 10, 2014 - 9:03am
tags:
Aastrom Biosciences, Vericel Corporation
Amgen eyes a speedy approval for its leukemia contender
Fierce Biotech
Friday, October 10, 2014 - 8:56am
tags:
Amgen, acute lymphoblastic leukemia, blinatumomab
Medicare Recommends $500 Reimbursement for Exact Sciences' Colon Cancer Test
TheStreet.com
Friday, October 10, 2014 - 8:55am
tags:
Medicare, EXACT Sciences, Cologuard, colon cancer, Chembio Diagnostics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.